HONG KONG SAR - Media OutReach Newswire - 18 May 2026 - Sequencio Therapeutics, a subsidiary of CK Life Sciences Int'l., (Holdings) Inc. ("CK Life Sciences", Stock Code: 0775) today announced the appointment of Emily Tan as Chief Operating Officer. A 30-year biopharmaceutical veteran, Ms Tan will oversee the company's global operations and drive execution across its development pipeline.
Ms Tan joins Sequencio Therapeutics with an extensive track record across global pharmaceutical companies, leading contract research organisations, and innovative biotechnology companies, bringing deep expertise in clinical development, operations, quality, regulatory execution, and commercial strategy.
Ms Tan most recently served as Senior Vice President, Business Development at IQVIA, where she led commercial activities in Asia Pacific and supported clients in developing and executing global integrated go-to-market strategies.
Her career includes C-suite roles at China-based biotech startups Unixell Biotechnology, Bennu Biotherapeutics, and Oricell Therapeutics, where she scaled operations and led successful global Investigational New Drug (IND) and China Investigator-Initiated Trial (IIT) submissions. She previously held leadership positions at PAREXEL, Syneos and Pfizer.
"Emily brings a rare combination of operational excellence, clinical development experience, and regional and global leadership," said Dr Melvin Toh, Vice President and Chief Scientific Officer of CK Life Sciences. "Her appointment strengthens Sequencio Therapeutics' leadership team as we advance our pipeline and build the operational foundation to support our next stage of growth."
"I am excited to join the Sequencio Therapeutics team at this important stage of its development," said Ms Tan. "Building on the company's strong scientific foundation, I look forward to strengthening operational capabilities and supporting the continued advancement of the pipeline."
Ms Tan holds a Bachelor of Science in Pharmacy (Honours) from the National University of Singapore and a Master of Science in Epidemiology from the London School of Hygiene and Tropical Medicine.
Hashtag: #CKLifeSciences #Sequencio #Therapeutics #COO #ChiefOperatingOfficer #CancerVaccines #R&D #Pharmaceutical #Biotechnology
The issuer is solely responsible for the content of this announcement.
Sequencio Therapeutics Company Limited
Sequencio Therapeutics Company Limited, a subsidiary of CK Life Sciences Int'l., (Holdings) Inc., is focused on developing next‑generation therapeutic cancer vaccines that harness a patient's own immune system to achieve durable, long‑term remission with a favourable safety profile, addressing key limitations of current standard‑of‑care therapies. Sequencio Therapeutics is driven by a long‑term vision to shift cancer treatment from transient tumour reduction toward sustained, immune‑controlled remission.
** This press release is distributed by Media OutReach Newswire through automated distribution system, for which the client assumes full responsibility. **
HONG KONG SAR - Media OutReach Newswire – 18 May 2026 - Doremi3babies is one of Hong Kong's most comprehensive retailers of Caraz baby playmats and playpens, with years of accumulated experience serving local families and maintaining quality standards for every product carried. Observing that size mismatches are among the most common issues parents encounter after purchase, Doremi3babies has drawn on its local service experience to compile a practical size selection reference based on actual Hong Kong residential floor areas, helping parents identify the most suitable mat size and playpen configuration for their home.
Space Is Limited in Hong Kong Homes — Choosing the Right Size Matters
According to Hong Kong's Census and Statistics Department 2021 Population Census, the median per capita residential floor area stands at approximately 172 sq ft. The latest Housing Bureau supply statistics (2025) show that 88% of private residential units currently in the development pipeline have a usable area of less than 70 square metres (approximately 753 sq ft). In a space-constrained home, a playmat that's even slightly misjudged in size can disrupt daily living — making preparation before purchase all the more important.
4 Steps to Choosing the Right Size
The following steps help parents confirm their needs before buying, reducing the chance of a mismatch after the mat arrives home:
1. Measure the net usable area: Measure the actual spot where the mat will be placed — deducting furniture and walkways from the total floor space, not the overall unit size.
2. Consider your baby's developmental stage: Crawling infants (approx. 4–10 months) need continuous flat surface area; toddlers (approx. 10–18 months) benefit more from playpen boundaries to define a safe zone.
3. Decide whether to pair with a playpen: If combining a mat with a playpen, calculate the usable area inside the playpen — not the mat's outer dimensions.
4. Choose the style based on your confirmed space: Once space constraints are clear, foldable or modular designs help maximise what's available.
A General Size Reference Based on Unit Floor Area
One of the most common mistakes Hong Kong parents make when buying a playmat is estimating size based on the total unit area, rather than the net usable floor space after accounting for furniture. The gap between the two is often what leads to a mismatch once the mat arrives home.
Caraz playmats, for example, offer a range from compact sizes suited to a corner of a single room, through to larger formats that can cover the main activity zone of a living area. Using net usable floor area as the starting point, the general reference is as follows:
* Under 200 sq ft: A mat around 70×140cm is a common starting point. The foldable design is especially practical — it can be stored upright against a wall when not in use, freeing up the living space.
* 300–400 sq ft: Mid-size options such as 120×160cm to 140×200cm are the most common choice among Hong Kong families, balancing play space with storage flexibility.
* 400 sq ft and above: Larger formats such as 160×200cm or above give infants a dedicated zone for crawling and first steps without compromising daily living.
If a playpen is being added alongside the mat, the playpen's overall outer footprint needs to be estimated separately — it cannot be read directly from the mat dimensions alone.
Three Practical Directions for Compact Homes
For families with limited floor area, these approaches are worth considering:
* Choose a foldable mat: Fold it away when not in use to free up everyday living space.
* Consider a modular playpen system: Adjustable configurations adapt to irregular room layouts without being locked into a fixed size.
* Base your size decision on net usable area: The right standard is whether it fits and gets used — not simply bigger is better.
Hashtag: #Doremi3babies
The issuer is solely responsible for the content of this announcement.
About Doremi3babies
Founded in Hong Kong in 2017, Doremi3babies is Hong Kong's most comprehensive Caraz retailer, offering the full product range — playmats, playpens, and baby houses — with new arrivals in sync with the Korean market. The company has served over 6,000 families and delivered more than 16,000 baby products, with every item personally tested by the store owner before introduction. All Caraz products are manufactured in Korea and meet KC and CE international safety certification standards.
For more playmat size recommendations, visit the Doremi3babies Caraz Playmat Buying Guide.
** This press release is distributed by Media OutReach Newswire through automated distribution system, for which the client assumes full responsibility. **
